Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin patch added to first-line chemotherapy for advanced non-small cell lung cancer
ACTRN12608000588392Phase 3Completed
- Sponsor
- University of Sydney
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of nitroglycerin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University of Sydney. Primary endpoint: Progression-free survival. Started May 2009; status: completed.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ACTRN12608000588392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000588392.